Brunvand, M W <br/><br/>
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.  [electronic resource] 

 -  Bone marrow transplantation  Jul 1996 
 - 131-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Purging<br/>Bone Marrow Transplantation--mortality<br/>Child<br/>Child, Preschool<br/>Clinical Trials as Topic<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Etoposide--administration & dosage<br/>Female<br/>Graft Survival<br/>Hematopoietic Cell Growth Factors--pharmacology<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Life Tables<br/>Lymphoma--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Autologous<br/>Treatment Outcome<br/>Whole-Body Irradiation